More Good News for Developing Marijuana Treatments
That’s good news for every medical cannabis company, and the people who’ve come to rely on weed for pain relief. Americans largely support medical cannabis, with about 84% in favor of the drug legalized for medical uses, Pew Research Center reports. Recreational cannabis use is less controversial than ever before with at least 61% in support.
How did what was once considered a lethal drug become something of a miracle cure?
The drug’s counter-culture reputation has shifted and lawmakers have gotten behind the need for research to validate medical treatment. Even the National Institutes of Health now lists medical uses for cannabis. Clearly, there are billions of dollars at stake in the rapidly expanding business. (Also good news for the new medical cannabis company who wants to stake a claim in the market.)
Compelling Benefits: Cannabis for Pain and Muscle Spasms Related to Multiple Sclerosis
Among the 100 or more cannabinoid chemical compounds in the marijuana plant, there are at least two active chemicals that researchers say have medicinal applications: cannabidiol (CBD), which impacts the brain without a high, and tetrahydrocannabinol (THC), which has pain-relieving properties and delivers the buzz.
THC can increase appetite and reduce nausea. It may also decrease pain, inflammation, and muscle control problems. CBD has been linked to reducing pain and inflammation, helping to control epileptic seizures, and treat mental illness and addictions.
Weed for pain is one of the most common reasons people request medical marijuana, according to one of the most comprehensive reports to date, released in January 2017 by the National Academies of Sciences, Engineering, and Medicine.
The report confirmed there is definitive evidence that cannabis is an effective treatment for chronic pain. Interestingly, too, the report said cannabis can help treat muscle spasms related to multiple sclerosis, the most widespread disabling neurological condition of young adults around the world.
The U.S. Food and Drug Administration (FDA) requires rigorous clinical trials in humans to determine the benefits and risks of a possible medication before giving the green light. It’s approved two medications that contain cannabinoid chemicals in pill form — dronabinol and nabilone — to treat the severe nausea caused by chemotherapy and to boost appetite in patients with AIDS respectively. These contain synthetic versions of THC, developed in the lab, to dial down its addictive properties and boost therapeutic effects.
This July, the FDA approved the liquid CBD extract-based medicine Epidiolex for rare childhood epilepsy disorders, Dravet syndrome, and Lennox-Gastaut syndrome, calling it a “breakthrough” to treat a horrible disease.
Bottom line, you may be visiting a medical cannabis company’s dispensary with assurance there are health benefits to be gained.